Company Filing History:
Years Active: 1993-2002
Title: Michel Bergh: Innovator in Enzymatic Research
Introduction
Michel Bergh is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of enzymatic research, particularly in the production of glucocerebrosidase. With a total of 2 patents, his work has implications for various medical applications.
Latest Patents
Michel Bergh's latest patents focus on enzymatically active recombinant glucocerebrosidase. This recombinant active glucocerebrosidase is produced by a eukaryotic cell. The patent details that the cell includes nucleic acid encoding enzymatically active glucocerebrosidase. Furthermore, a eukaryotic organism contains such a cell. The method for producing enzymatically active glucocerebrosidase involves introducing glucocerebrosidase-encoding nucleic acid into a eukaryotic cell, causing the cell to express glucocerebrosidase, and purifying the glucocerebrosidase from the cell.
Career Highlights
Michel Bergh is currently associated with Genzyme Corporation, where he continues to advance his research in enzymatic processes. His work has been pivotal in enhancing the understanding and production of glucocerebrosidase, which is crucial for certain medical treatments.
Collaborations
Some of his notable coworkers include James R. Rasmussen and Gary D. Barsomian. Their collaborative efforts contribute to the innovative research environment at Genzyme Corporation.
Conclusion
Michel Bergh's contributions to enzymatic research and his patents in glucocerebrosidase production highlight his role as a significant inventor in the field. His work continues to influence advancements in medical science.